Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation

Figure 1 Circulating interleukin-33 levels in recipients immediately following reperfusion. A: Elevation of interleukin-33 was observed in recipients implanted with moderate macrosteatotic grafts. B and C: Higher levels of both alanine aminotransferase and aspartate transaminase (IU/L) were in recipients with detectable interleukin-33 levels following liver reperfusion. ^aP < 0.05, ^bP < 0.01. IL-33: Interleukin-33; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.

Figure 2 Complement activation in recipients of moderate macrosteatotic grafts. A: Elevated levels of activated complement C3a was observed in recipients implanted with moderate macrosteatotic grafts immediately following liver reperfusion; B: Elevated levels of activated complement C5a was observed in recipients implanted with moderate macrosteatotic grafts immediately following liver reperfusion. ^aP < 0.05, ^bP < 0.01.